Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary


Por: Marks, DI, Cassaday, RD, Ribera, JM, Schuh, AC, Park, JH, Chiaretti, S and Stelljes, M

Publicada: 4 may 2025 Ahead of Print: 1 may 2025
Resumen:


Filiaciones:
Marks, DI:
 Univ Hosp Bristol NHS Trust, Bristol, England

Cassaday, RD:
 Univ Washington, Seattle, WA USA

 Fred Hutchinson Canc Ctr, Seattle, WA USA

:
 Inst Catala Oncol, Barcelona, Spain

 Josep Carreras Res Inst, Barcelona, Spain

Schuh, AC:
 Canc Clin Res Unit, Toronto, ON, Canada

Park, JH:
 Mem Sloan Kettering Canc Ctr, New York, NY USA

Chiaretti, S:
 Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy

Stelljes, M:
 Univ Munster, Munster, Germany
ISSN: 17474086





Expert Review of Hematology
Editorial
Taylor & Francis, 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND, Reino Unido
Tipo de documento: Editorial Material
Volumen: 18 Número: 5
Páginas: 345-349
WOS Id: 001491622700001
ID de PubMed: 40394810
imagen Bronze

MÉTRICAS